You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Investigational Drug Information for Prinomastat


✉ Email this page to a colleague

« Back to Dashboard


What is the drug development status for Prinomastat?

Prinomastat is an investigational drug.

There have been 3 clinical trials for Prinomastat. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 1998.

The most common disease conditions in clinical trials are Carcinoma, Non-Small-Cell Lung, Prostatic Neoplasms, and Nervous System Neoplasms. The leading clinical trial sponsors are Pfizer and [disabled in preview].

Recent Clinical Trials for Prinomastat
TitleSponsorPhase
Prinomastat Plus Temozolomide Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformePfizerPhase 2
Prinomastat and Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Non-small Cell Lung CancerPfizerPhase 3
Chemotherapy in Treating Patients Who Have Metastatic Prostate CancerPfizerPhase 3

See all Prinomastat clinical trials

Clinical Trial Summary for Prinomastat

Top disease conditions for Prinomastat
Top clinical trial sponsors for Prinomastat

See all Prinomastat clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.